Novan to Participate in JMP Securities Life Sciences Conference
June 13 2019 - 9:15AM
Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today
announced that it will participate in the 2019 JMP Securities Life
Sciences Conference in New York on Thursday, June 20, 2019.
Participation will include a fireside chat as well as a Q&A
session. The company will also have a number of one-on-one meetings
with investors during the conference.
The fireside chat will occur on June 20, 2019 at
9:30 a.m. Eastern. The presentation will be webcast live and can be
accessed through the Investors section of the Company's website at
www.Novan.com. An archived version of the webcast will be available
approximately two hours following the live presentation for 7
days.
About Novan
Novan, Inc. is a clinical development-stage
biotechnology company focused on leveraging nitric oxide’s
naturally occurring anti-microbial and immunomodulatory mechanisms
of action to treat a range of diseases with significant unmet
needs. We believe that our ability to deploy nitric oxide in a
solid form, on demand and in localized formulations allows us the
potential to improve patient outcomes in a variety of
dermatological, women’s health and gastrointestinal diseases.
CONTACT:
(Investors & Media)Cole IkkalaDirector,
Investor Relations, Communications & Business
Developmentcikkala@novan.com
Novan (NASDAQ:NOVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novan (NASDAQ:NOVN)
Historical Stock Chart
From Apr 2023 to Apr 2024